Greg Moeck
VenatoRx Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Antibiotics Pharmacokinetics and Efficacy, Antimicrobial Resistance in Staphylococcus, Antibiotic Resistance in Bacteria, Bacterial Identification and Susceptibility Testing, Bacterial Genetics and Biotechnology
Most-Cited Works
- → TonB‐dependent iron acquisition: mechanisms of siderophore‐mediated active transport†(1998)306 cited
- → Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections(2014)301 cited
- → Antimicrobial drug discovery through bacteriophage genomics(2004)235 cited
- → Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study(2014)216 cited
- → VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa(2019)208 cited
- → Oritavancin Kills Stationary-Phase and BiofilmStaphylococcus aureusCells In Vitro(2008)174 cited